Cancer News and Research

Latest Cancer News and Research

Halloween parties can heighten danger for kids with food allergies

The scary reality is that food allergies are becoming more and more common in the United States. In the past 10 years there has been an 18 percent increase in children with food allergies.

10 Oct 2013

Researcher receives grant to explore HER2-positive breast tumor susceptibility to PARP inhibitors

Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.

10 Oct 2013

Noninvasive tool created to detect pancreatic cancer through risk assessment test using saliva

Pancreatic cancer is one of the deadliest forms of cancer. Most of those with the disease will die within the first year of diagnosis, and just 6 percent will survive five years.

10 Oct 2013

Scientists create model in battle against adenomyosis

For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.

10 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Research points to causes, potential treatment approaches for systemic sclerosis

Using mice, lab-grown cells and clues from a related disorder, Johns Hopkins researchers have greatly increased understanding of the causes of systemic sclerosis, showing that a critical culprit is a defect in the way certain cells communicate with their structural scaffolding

10 Oct 2013

Key findings may have broad implications for future scleroderma therapy

The Scleroderma Research Foundation today said that researchers at The Johns Hopkins University working in a novel mouse model of Stiff Skin Syndrome have made key discoveries that may have broad implications for future scleroderma therapy.

10 Oct 2013

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what's good for one disease may not be good for another.

10 Oct 2013

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.

10 Oct 2013

HIV infection heralds worse outcomes in NSCLC

Infection with HIV is an indicator of poor prognosis in patients with non-small-cell lung cancer, analysis of epidemiologic data indicates.

9 Oct 2013

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that it has entered into a strategic advisory agreement with H.C. Wainwright & Co., LLC.

9 Oct 2013

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals.

9 Oct 2013

Thwarting Greatwall May Trigger Mitotic Collapse And Suppress Tumor Development

...

9 Oct 2013

Active Biotech And Hutchison China Meditech Get Rewarded

...

9 Oct 2013

U.S. Research Will "Pay Dearly" For Shutdown, ASCB Warns

...

9 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

HMI, NCONN to collaborate on various educational initiatives for oncology health professionals

Haymarket Media Inc. and the National Coalition of Oncology Nurse Navigators have formed a partnership to collaborate on a wide variety of educational initiatives for the oncology health professionals they serve.

9 Oct 2013

Delivering more personalized care for breast cancer patients

By studying the genetic makeup of breast cancer patients, doctors are taking the next steps forward in delivering more personalized care to patients. Whole genome sequencing from cancers is not a new concept, but recently researchers have delved more deeply into the evolution of breast cancers identifying that it comes in four distinct types.

9 Oct 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).

9 Oct 2013

$Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases$

Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases

Justin E. Bekelman, M.D., of the University of Pennsylvania Perelman School of Medicine, Philadelphia, and colleagues conducted a study to examine whether single-fraction radiation treatment, shown to be as effective as multiple-fraction treatment with less potential for harm, has been incorporated into routine clinical practice for Medicare beneficiaries with prostate cancer and at what cost savings.

9 Oct 2013

Cancer News and Research

Latest Cancer News and Research

Halloween parties can heighten danger for kids with food allergies

Researcher receives grant to explore HER2-positive breast tumor susceptibility to PARP inhibitors

Noninvasive tool created to detect pancreatic cancer through risk assessment test using saliva

Scientists create model in battle against adenomyosis

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Research points to causes, potential treatment approaches for systemic sclerosis

Key findings may have broad implications for future scleroderma therapy

High levels of HDL have been linked to increased breast cancer risks, enhance cancer aggressiveness

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

HIV infection heralds worse outcomes in NSCLC

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Thwarting Greatwall May Trigger Mitotic Collapse And Suppress Tumor Development

Active Biotech And Hutchison China Meditech Get Rewarded

U.S. Research Will "Pay Dearly" For Shutdown, ASCB Warns

Compugen drug candidate prevents autoimmune type I diabetes in animal model

HMI, NCONN to collaborate on various educational initiatives for oncology health professionals

Delivering more personalized care for breast cancer patients

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

Study examines use of single-fraction radiation treatment for prostate cancer, bone metastases

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in